Table 2 Clinical characteristics of patients treated with PDT before surgical removal of the CNV.
| Case | Eye | Age/sex | CNV type | Visual acuity | PDT treatments | Time to surgery from PDT/ last PDT |
|---|---|---|---|---|---|---|
| 1 | L | 76/M | classic | 0.025 | 1 | 3 days |
| 2 | R | 78/F | classic | 0.02 | 1 | 3 days |
| 3 | L | 54/M | predominantly classic | 0.063 | 2 | 113/3 days |
| 4 | L | 84/M | classic | 0.025 | 1 | 3 days |
| 5 | L | 83/M | classic | 0.03 | 1 | 34 days |
| 6 | L | 85/F | classic | 0.03 | 1 | 37 days |
| 7 | R | 73/F | occult | 0.1 | 3 | 208/138/40 days |
| 8 | L | 79/M | classic | 0.1 | 1 | 55 days |
| 9 | L | 77/M | minimally classic | 0.6 | 1 | 84 days |
| 10 | L | 76/F | occult | 0.6 | 1 | 105 days |
| 11 | L | 81/M | classic | 0.08 | 2 | 213/131 days |
| 12 | L | 78/F | classic | 0.05 | 3 | 344/222/146 days |
CNV, choroidal neovascular membrane; PDT, photodynamic therapy.